Vyome (NASDAQ:HIND) Raised to Hold at Zacks Research

Vyome (NASDAQ:HIND) was upgraded by analysts at Zacks Research to a “hold” rating in a report released on Wednesday,Zacks.com reports.

Other analysts have also issued reports about the company. Weiss Ratings upgraded Vyome from a “sell (e)” rating to a “sell (e+)” rating in a research report on Friday, May 1st. Litchfield Hills Research assumed coverage on Vyome in a research report on Monday. They set a “buy” rating for the company. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $15.00.

Vyome Stock Down 4.5%

Shares of HIND stock opened at $2.10 on Wednesday. The stock has a 50-day moving average price of $2.38 and a 200 day moving average price of $3.44. The firm has a market cap of $14.74 million, a price-to-earnings ratio of -0.02 and a beta of 1.38. Vyome has a 12 month low of $1.75 and a 12 month high of $34.30.

Hedge Funds Weigh In On Vyome

An institutional investor recently bought a new position in Vyome stock. Geode Capital Management LLC bought a new stake in Vyome Holdings, Inc. (NASDAQ:HIND) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 11,934 shares of the company’s stock, valued at approximately $41,000. Geode Capital Management LLC owned approximately 0.21% of Vyome as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 22.06% of the company’s stock.

Vyome Company Profile

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.